Li, Pengyun
Hu, Xiaotong
Fan, Zhiya
Sun, Shiyang
Ran, Qijie
Wei, Ting
Wei, Pengli
Jiang, Qiyu
Yan, Jian
Yang, Ning
Jia, Changkai
Yang, Tingting
Mao, Yaqiu
Cai, Xu
Xu, Tingting
Zhao, Zhiyuan
Qian, Xiaohong
Qin, Weijie
Zhuang, Xiaomei
Fan, Feng
Xiao, Junhai
Zheng, Zhibing
Li, Song
Funding for this research was provided by:
State Key Laboratory of National Security Specially Needed Medicines Program (LTMC2022ZZ006, LTMC2022ZZ006)
National Natural Science Foundation of China (32371504, 32371504)
Article History
Received: 22 June 2024
Accepted: 5 August 2024
First Online: 2 September 2024
Declarations
:
: All animal studies were performed strictly in accordance with the Animal Care Guidelines approved by the Institutional Animal Care Committee of Beijing Institute of Biotechnology. The human related materials were included MM cells and tumor tissues, and the use of human experimental materials, including cDNA derived from cell lines and clinical specimens, have been reviewed and approved by Ethics Committee of the General Hospital of Central Theater Command. All the experiments using the human related materials were performed according to the Helsinki Declaration (WHO).
: Not applicable.
: The authors declare no competing interests.